Previous Article | Next Article ![]()
J. Virol., 12 1997, 9180-9187, Vol 71, No. 12
PG Conaldi, L Biancone, A Bottelli, A De Martino, G Camussi and A Toniolo
The six group B coxsackieviruses (CVBs) are highly prevalent human
pathogens that cause viremia followed by involvement of different organs.
Clinical and experimental evidence suggests that CVBs can induce kidney
injury, but the susceptibility of human renal cells to these viruses is
unknown. By using pure cultures of human glomerular and tubular cells, we
demonstrated that all CVBs are capable of productively infecting renal
cells of three different histotypes. Distinct pathogenic effects were
observed. Proximal tubular epithelial cells and, to a lesser extent,
glomerular podocytes were highly susceptible to CVBs; in both cases,
infection led to cytolysis. In contrast, glomerular mesangial cells
supported the replication of the six CVBs but failed to develop overt
cytopathologic changes. Mesangial cells continued to produce infectious
progeny for numerous serial subcultures (i.e., more than 50 days),
especially with type 1, 3, 4, and 5 viruses. In the above cells, persistent
infection induced the de novo synthesis of platelet-derived growth factor
A/B and enhanced the release of transforming growth factor beta1/2. These
two factors are important mediators of progression from glomerular
inflammation to glomerulosclerosis. CVB replication appeared also to impair
the phagocytic and contractile activity of mesangial cells. Loss of these
properties--which are important in glomerular physiopathology--may
contribute to the development of progressive nephropathy. The results show
that CVBs induce distinct effects in different types of cultured renal
cells and suggest that CVB infections may be associated with both acute and
progressive renal injury.
Copyright © 1997, American Society for Microbiology
Distinct pathogenic effects of group B coxsackieviruses on human glomerular and tubular kidney cells
Department of Clinical and Biological Sciences, University of Pavia, Varese, Italy.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|